Ketogenic diet and cognition in neurological diseases: a systematic review

Nutr Rev. 2021 Jun 4;79(7):802-813. doi: 10.1093/nutrit/nuaa113.

Abstract

Context: In recent years, the ketogenic diet has gained special relevance as a possible therapeutic alternative to some neurological and chronic diseases.

Objective: The aim of this systematic review was to answer the following question: Does a ketogenic diet improve cognitive skills in patients with Alzheimer's disease, Parkinson's disease, refractory epilepsy, and type 1 glucose deficiency syndrome? To define the research question, the PICOS criteria were used, following the guidelines of the PRISMA method.

Data sources: Medline/PubMed, Elsevier Science Direct, Dialnet, EBSCOhost, Mediagraphic, Sage Journals, ProQuest, and Wiley Online Library databases were used.

Data extraction: After applying inclusion and exclusion criteria in accordance with the PRISMA method, a total of 63 entries published between 2004 and 2019 were used.

Data analysis: The records extracted were analyzed from a qualitative approach, so no statistical analysis was carried out.

Conclusion: Although scientific literature on the subject is scarce and there has tended to be a lack of scientific rigor, the studies reviewed confirmed the effectiveness of this diet in improving the cognitive symptomatology of the aforementioned diseases.

Keywords: Alzheimer's disease; Parkinson's disease; cognition; glucose transporter deficiency syndrome type 1; ketogenic diet; ketosis; low carbohydrate diet; refractory epilepsy; β-hydroxybutyrate.

Publication types

  • Systematic Review

MeSH terms

  • Alzheimer Disease / diet therapy
  • Cognition*
  • Diet, Ketogenic*
  • Humans
  • Nervous System Diseases* / diet therapy
  • Parkinson Disease / diet therapy